New JerseyA3852220th Legislature (2024-2025)House

Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million.*

Sponsored By: Clinton Calabrese (Democratic), Anthony S. Verrelli (Democratic)

Failed

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsors

  • Clinton Calabrese

    Democratic • House

  • Anthony S. Verrelli

    Democratic • House

Cosponsors

  • Kevin P. Egan

    Democratic • House

  • Shama A. Haider

    Democratic • House

  • Shanique Speight

    Democratic • House

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Substituted by S2283 (SCS/2R)

    1/12/2026House
  2. Reported, 2nd Reading in Assembly

    12/18/2025House
  3. REP/ACS, Referred to Assembly Appropriations Committee

    11/24/2025House
  4. NOT, REP/ACS Assembly Health Committee

    6/17/2024House
  5. Introduced, 1st Reading in Assembly, Referred to Assembly Health Committee

    2/22/2024House

Bill Text

  • Assembly Health Substitute (11/24/25 ACS ACS)

    1/12/2026

  • Assembly Appropriations Substitute (12/18/25 ACS)

    12/19/2025

  • 12/18/25; ACS ACS

    12/18/2025

  • Assembly Health (11/24/25 ACS ACS)

    11/25/2025

  • Assembly Health (6/17/24 ACS)

    3/10/2025

  • As Introduced

    6/18/2024

  • Assembly Health Substitute (6/17/24 ACS)

    6/18/2024

  • 5/8/24; as introduced

    5/8/2024

Related Bills

Back to State Legislation